<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34607587</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1471-2490</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>21</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Oct</Month>
              <Day>04</Day>
            </PubDate>
          </JournalIssue>
          <Title>BMC urology</Title>
          <ISOAbbreviation>BMC Urol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Systemic and intrathecal baclofen produce bladder antinociception in rats.</ArticleTitle>
        <Pagination>
          <StartPage>139</StartPage>
          <MedlinePgn>139</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">139</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12894-021-00899-0</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Baclofen, a clinically available GABA<sub>B</sub> receptor agonist, produces non-opioid analgesia in multiple models of pain but has not been tested for effects on bladder nociception.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A series of experiments examined the effects of systemic and spinally administered baclofen on bladder nociception in female anesthetized rats. Models of bladder nociception included those which employed neonatal and adult bladder inflammation to produce bladder hypersensitivity.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Cumulative intraperitoneal dosing (1-8 mg/kg IP) and cumulative intrathecal dosing (10-160 ng IT) of baclofen led to dose-dependent inhibition of visceromotor responses (VMRs) to urinary bladder distension (UBD) in all tested models. There were no differences in the magnitude of the analgesic effects of baclofen as a function of inflammation versus no inflammation treatments. Hemodynamic (pressor) responses to UBD were similarly inhibited by IT baclofen as well as UBD-evoked excitatory responses of spinal dorsal horn neurons. The GABA<sub>B</sub> receptor antagonist, CGP 35,348, antagonized the antinociceptive effects of IT baclofen on VMRs in all tested models but did not affect the magnitude of the VMRs by itself suggesting no tonic GABA<sub>B</sub> activity was present in this preparation. Tolerance to a seven day continuous IT infusion of baclofen was not observed.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These data provide support for a clinical trial of baclofen as a non-opioid treatment of human bladder pain.</AbstractText>
          <CopyrightInformation>© 2021. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ness</LastName>
            <ForeName>Timothy J</ForeName>
            <Initials>TJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, BMR2-208, 901 19th Street South, Birmingham, AL, 35294, USA. tness@uabmc.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Randich</LastName>
            <ForeName>Alan</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, BMR2-208, 901 19th Street South, Birmingham, AL, 35294, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Su</LastName>
            <ForeName>Xin</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Medtronics, Inc., Minneapolis, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>DeWitte</LastName>
            <ForeName>Cary</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, BMR2-208, 901 19th Street South, Birmingham, AL, 35294, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hildebrand</LastName>
            <ForeName>Keith</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Medtronics, Inc., Minneapolis, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 DK051413</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>DK51413</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>04</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>BMC Urol</MedlineTA>
        <NlmUniqueID>100968571</NlmUniqueID>
        <ISSNLinking>1471-2490</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D058786">GABA-B Receptor Agonists</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>H789N3FKE8</RegistryNumber>
          <NameOfSubstance UI="D001418">Baclofen</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001418" MajorTopicYN="N">Baclofen</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058786" MajorTopicYN="N">GABA-B Receptor Agonists</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007278" MajorTopicYN="N">Injections, Spinal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059225" MajorTopicYN="N">Nociception</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001743" MajorTopicYN="N">Urinary Bladder</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Antinociception</Keyword>
        <Keyword MajorTopicYN="N">GABAB receptors</Keyword>
        <Keyword MajorTopicYN="N">Interstitial cystitis/bladder pain syndrome</Keyword>
        <Keyword MajorTopicYN="N">Urinary bladder</Keyword>
      </KeywordList>
      <CoiStatement>KH and XS were employees of Medtronic, Inc which manufactures pumps which are used in infuse baclofen in humans. TJN, AR and CD work for the University of Alabama at Birmingham which received a grant from Medtronic, Inc. to support these studies.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>5</Day>
          <Hour>5</Hour>
          <Minute>34</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34607587</ArticleId>
        <ArticleId IdType="pmc">PMC8489106</ArticleId>
        <ArticleId IdType="doi">10.1186/s12894-021-00899-0</ArticleId>
        <ArticleId IdType="pii">10.1186/s12894-021-00899-0</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Kent CN, Park C, Lindsley CW. Classics in chemical neuroscience: baclofen. ACS Chem Neurosci. 2020;11:1740–1755.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32436697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bendtsen L, Zakrewska JM, Abbott J, Braschinsky M, et al.  European Academy of Neurology guideline on trigeminal neuralgia. Eur J Neurol. 2019;26:831–849.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30860637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harmer JP, Larson BS. Pain relief from baclofen analgesia in a neuropathic pain patient who failed opioid and pharmacotherapy: case report. J Pain Palliat Care Pharmacother. 2002;16:61–64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14640356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao W, Naso L, Bennett GJ. Experimental studies of potential analgesics for the treatment of chemotherapy-evoked painful neuropathies. Pain Med. 2008;9:505–517.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18777607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ness TJ, McNaught J, Clodfelder-Miller B, Su X. Medications used to treat bladder disorders may alter effects of neuromodulation. Neurourol Urodyn. 2020;39:1313–1320.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7337973</ArticleId>
            <ArticleId IdType="pubmed">32330365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. MMWR. 2016;65:1–52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26987082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aley KO, Kulkarni SK. GABAergic agents-induced antinociceptive effect in mice. Methods Find Exp Clin Pharmcol. 1989;11:597–601.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2511384</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aley KO, Kulkarni SK. Baclofen analgesia in mice: a GABA B mediated mechanism. Methods Find Exp Clin Pharmcol. 1991;13:681–686.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1663195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aran S, Hammond DL. Antagonisms of baclofen-induced antinociception by intrathecal administration of phaclofen or 2-hydroxy-saclofen, but not δ-aminovaleric acid in the rat. J Pharm Exp Ther. 1991;257:360–368.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1850472</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Citterio F, Corrandini L, Smith RD, Bertorelli R. Nociceptin attenuates opioid and GABA-B receptor-mediated analgesia in the mouse tail-flick assay. Neurosci Lett. 2000;292:83–86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10998554</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dirig DM, Yaksh TL. Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model. J Pharm Exp Ther. 1996;275:219–227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7562553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jasmin L, Rabkin SD, Granato A, Boudah A, Ohara PT. Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex. Nature. 2003;424:316–320.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12867983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalinichev M, Palea S, Haddouk H, Royer-AUrios I, Guilloteau V, Lluel P, Schneider M, Saporito M, Poli S. ADX71441, a novel, potent and selective positive allosteric modulator of the GABA-B receptor, shows efficacy in rodent models of overactive bladder. Br J Pharmacol. 2014;171:995–1006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3925038</ArticleId>
            <ArticleId IdType="pubmed">24224799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naderi N, Shafaghi B, Khodayar MJ, Zarindast MR. Interaction between GABA-B amd CB1 receptors in spinal pain pathways in rat. Eur J Pharmacol. 2005;514:159–164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15910802</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pedron VT, Varani AP, Bettler B, Balerio GN. GABA-B receptors modulate morphine antinociception: pharmacological and genetic approaches. Pharmacol Biochem Behav. 2019;180:11–21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30851293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tamayo L, Rifo J, Contreras E. Influence of adrenergic and cholinergic mechanisms in baclofen induced analgesia. Gen Pharmacol. 1988;19:87–89.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3345902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tambeli LJD, Gear RW. Centralization of noxious stimulus-induced analgesia (NSIA) is related to activity at inhibitiory synapses in the spinal cord. Pain. 2009;143:228–232.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2693265</ArticleId>
            <ArticleId IdType="pubmed">19375225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomas DA, McGowan MK, Hammond DL. Microinjection of baclofen in the ventromedial medulla of rats: antinociception at low doses and hyperalgesia at high doses. J Pharm Exp Therapeut. 1995;275:274–284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7562560</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tokuyama S, Takahashi M, Kaneto H. Participation of GABAergic systems in the production of antinociception by various stresses in mice. Jpn J Pharmacol. 1992;60:105–110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1336079</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zarrindast MR, Djavdan M. GABA-A-antagonists and baclofen analgesia. Gen Pharmacol. 1988;19:703–706.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3215482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim CR, Garant DS, Gale K. GABA agonist induced analgesia elicited from the lateral preoptic area in the rat. Eur J Pharmacol. 1984;107:91–94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6098483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharma R, Mathur R, Nayar U. GABA B mediated analgesia in tonic pain in monkeys. Indian J Physiol Pharmacol. 1993;37:189–193.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8276493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Whitehead RA, Puil E, Ries CR, Schwarz SK, Wall RA, Cooke JE, Putrenko I, Sallam NA, MacLeod BA. GABA(B) receptor-mediated selective peripheral analgesia by the non-proteinogenic amino acid, isovaline. Neuroscience. 2012;213:154–160.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22525135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taira T, Kawamura H, Tanikawa T, Iseki H, Kawabatake H, Takakura K. A new approach to control central deafferentation pain: spinal intrathecal baclofen. Stereotact Funct Neurosurg. 1995;65(1–4):101–105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8916336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gordon NC, Gear RW, Heller PH, Paul S, Miaskowski C, Levine JD. Enhancement of morphine analgesia by the GABA B agoinist baclofen. Neuroscience. 1995;69:345–349.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8552232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panerai AE, Massei R, deSilva E, Sacerdote P, Monza G, Mantegazza P. Baclofen prolongs the analgesic effect of fentanyl in man. Br J Anaesth. 1985;57:954–955.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4041321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Corli O, Roma G, Bacchini M, Battagliarin G, DiPiazza D, Brambilla C, Grossi E. Double-blind placebo-controlled trial of baclofen, alone and in combination, in patients undergoing voluntary abortion. Clin Ther. 1984;6:800–807.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6391666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spano MS, Fattore L, Fratta W, Fadda P. The GABA-B receptor agonist baclofen prevents heroin-induced reinstatement of heroin-seeking behavior in rats. Neuropharmacology. 2007;52:1555–1562.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17451755</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DiCiano P, Everitt BJ. The GABA-B receptor agonist baclofen attenuates cocaine- and heroin-seeking behavior by rats. Neuropsychopharmcol. 2003;28:510–518.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12629530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bartoletti M, Ricci F, Gaiardi M. A GABA(B) agonist reverses the behavioral sensitization to morphine in rats. Psychopharmacology. 2007;192(1):79–85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17242923</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heinrichs SC, Leite-Morris KA, Carey RJ, Kaplan GB. Baclofen enhances extinction of opiate conditioned place preference. Behav Brain Res. 2010;207:353–359.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19840820</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Voigt RM, Herrold AA, Napier TC. Baclofen facilitates the extinction of methamphetamine-induced conditioned place preference in rats. Behav Neurosci. 2011;125:261–267.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3076791</ArticleId>
            <ArticleId IdType="pubmed">21463025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ness TJ, Lewis-Sides A, Castroman P. Characterization of pressor and visceromotor reflex responses to bladder distension in rats: sources of variability and effect of analgesics. J Urol. 2001;165:968–974.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11176524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bogart LM, Berry SH, Clemens JQ. Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review. J Urol. 2007;177:450–456.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17222607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ball CL, Ness TJ, Randich A. Opioid blockade and inflammation reveal estrous cycle effects on visceromotor reflexes evoked by bladder distension. J Urol. 2010;184:1529–1535.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20723927</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Randich A, Uzzell TW, Cannon RS, Ness TJ. Inflammation and enhanced nociceptive responses to bladder distension produced by intravesical zymosan in the rat. BMC Urol. 2006;6:2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1395324</ArticleId>
            <ArticleId IdType="pubmed">16469099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Randich A, Uzzell TW, DeBerry JJ, Ness TJ. Neonatal urinary bladder inflammation produces adult bladder hypersensitivity. J Pain. 2006;7:469–479.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16814686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xin S, Riedel ES, Leon LA, Laping NJ. Pharmacologic evaluation of pressor and visceromotor reflex responses to bladder distension. Neurourol Urodyn. 2008;27:249–253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17598175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blatt LK, Lashinger ES, Laping NJ, Su X. Evaluation of pressor and visceromotor reflex responses to bladder distension in urethane anesthetized rats. Neurourol Urodyn. 2009;28:442–446.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19030181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ness TJ, Castroman P. Evidence for two populations of rat spinal nociceptive neurons excited by urinary bladder distension. Brain Res. 2001;923:147–156.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11743982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saulino M. The use of intrathecal baclofen in pain management. Neuromod. 2016;19:623–631.</Citation>
        </Reference>
        <Reference>
          <Citation>DeBerry J, Ness TJ, Robbins MT, Randich A. Inflammation-induced enhancement of the visceromotor reflex to urinary bladder distention: modulation by endogenous opioids and the effects of early-in-life experience with bladder inflammation. J Pain. 2007;8:914–923.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4012257</ArticleId>
            <ArticleId IdType="pubmed">17704007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeBerry J, Randich A, Shaffer AD, Robbins MT, Ness TJ. Neonatal bladder inflammation produces functional changes and alters neuropeptide content in bladders of adult female rats. J Pain. 2010;11:247–255.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2835826</ArticleId>
            <ArticleId IdType="pubmed">19945355</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ness TJ, Randich A, Robbins M, et al.  Early-in-life bladder inflammation results in clinical features of interstitial cystitis. Soc Neurosci. 2014;148(3):2014.</Citation>
        </Reference>
        <Reference>
          <Citation>Randich A, Mebane H, Ness TJ. Ice water testing reveals hypersensitivity in adult rats that experienced neonatal bladder inflammation: implications for painful bladder syndrome/interstitial cystitis. J Urol. 2009;182:337–342.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19447422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grinberg K, Sela Y, Nissanholtz-Gannot R. New insights about chronic pelvic pain syndrome (CPPS) Int J Environ Res Pub Health. 2020;17:3005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7246747</ArticleId>
            <ArticleId IdType="pubmed">32357440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grinberg K, Weissman-Fogel I, Lowenstein L, Abramov L, Granot M. How does myofascial physical therapy attenuate pain in chronic pelvic pain syndrome? Pain Res Manag. 2019;2019:6091257.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6930783</ArticleId>
            <ArticleId IdType="pubmed">31915499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adamian L, Urits I, Orhurhu V, Hoyt D, Driessen R, Freeman JA, Kaye AD, Kayye RJ, Garcia AJ, Cornett EM, Viswanath O. A comprehensive review of the diagnosis, treatment and management of urologic chronic pelvic pain syndrome. Pain Manag. 2012;2:603–608.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32378039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dias N, Zhang C, Spitznagle T, Lai HH, Zhang Y. High-density surface electromyography assessment of pelvic floor dysfunction in women with interstitial cystitis/bladder pain syndrome. J Urol. 2020;204:1275–1283.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32628100</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Halder GE, Scott L, Wyman A, Mora N, Miladinovic B, Bassaly R, Hoyte L. Botox combined with myofascial release physical therapy as a treatment for myofascial pelvic pain. Investig Clin Urol. 2017;58:134–139.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5330376</ArticleId>
            <ArticleId IdType="pubmed">28261683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen C-L, Meng E. Can botulinum toxin A play a role in Treatment of chronic pelvic pain syndrome in female patients? Clinical and animal evidence. Toxins. 2020;12:110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7076794</ArticleId>
            <ArticleId IdType="pubmed">32050685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen C-H, Tyagi P, Chuang Y-C. Promise and the pharmacological mechanism of botulinum toxin A in chronic prostatitis syndrome. Toxins. 2019;11:586.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6832516</ArticleId>
            <ArticleId IdType="pubmed">31614473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watanabe T, Perkash R, Constantinou CE. Modulation of detrusor contraction strength and micturition characteristics by intrathecal baclofen in anesthetized rats. J Urol. 1997;157:2361–2365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9146671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maggi CA, Santicioli P, Giuliani S, Furio M, Conte B, Meli P, Gragnani L, Meli A. The effects of baclofen on spinal and supraspinal micturition reflexes in rats. Naunyn Schmiedebergs Arch Pharmacol. 1987;336:197–203.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2825042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Magora F, Shazar N, Drenger B. Urodynamic studies after intrathecal administration of baclofen and morphine in dogs. J Urol. 1989;141:143–147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2908942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giuliani S, Lecci A, Santiciolo P, Del Bianco E, Maggi CA. Effect of the GABA-B antagonist, phaclophen, on baclofen-induced inhibition of micturition reflex in urethane-anesthetized rats. Neurosci. 1992;48:217–233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1316570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kontani H, Kawabata Y, Koshiura R. The effect of baclofen on the urinary bladder contraction accompanying micturition in anesthetized rats. Japan J Pharmacol. 1988;46:7–15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3367548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kontani H, Nakagawa M, Sakai T. Effects of central nervous system-acting drugs on urinary bladder contraction in unanesthetized rats. Jpn J Pharmacol. 1989;50:327–332.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2761133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kontani H, Ueda Y. A method for producing overactive bladder in the rat and investigation of the effects of GABAergic receptor agonists and glutaminergic receptor antagonists on the cystometrogram. J Urol. 2005;173:1805–1811.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15821592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chin HY, Lin KC, Chiang CH, Wang CJ. Combinatino of baclofen and antimuscarinics to reduce voiding difficulty in treating women with overactive bladders. Clin Exp Obstet Gynecol. 2012;39:171–174.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22905457</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nanninga JB, Frost F, Penn R. Effect of intrathecal baclofen on bladder and sphincter function. J Urol. 1989;142:101–105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2733083</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steers WD, Meythaler JM, Haworth C, Herrell D, Park TS. Effects of acute bolus and chronic continuous intrathecal baclofen on genitourinary dysfunction due to spinal cord pathology. J Urol. 1992;148:1849–1855.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1433619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Talalla A, Grundy D, Macdonell R. The effect of intrathecal baclofen on the lower urinary tract in paraplegia. Paraplegia. 1990;28:420–427.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2250984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bushman W, Steers WD, Meythaler JM. Voiding dysfunction in patients with spastic paraplegia: urodynamic evaluation and response to continuous intrathecal baclofen. Neurourol Urodyn. 1993;12:163–170.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7920673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frost F, Nanninga J, Penn R, Savoy S, Wu Y. Intrathecal baclofen infusion. Effect on bladder management programs in patients with myelopathy. Am J Phys Med Rehab. 1989;68:112–115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2730779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vignes JR, Deloire MS, Petry KG, Nagy F. Characterization and restoration of altered inhibitory and excitatory control of micturition reflex in experimental autoimmune encephalomyelitis in rats. J Physiol. 2007;578:439–450.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2075159</ArticleId>
            <ArticleId IdType="pubmed">17068103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kanie S, Yokoyama O, Komatsu K, Kodama K, Yotsuyanagi S, Niikura S, Nagasaka Y, Miyamoto K-I, Nmiki M. GABAergic contribution to rat bladder hyperactivity after middle cerebral artery occlusion. Am J Physiol. 2000;279:R1230–R1238.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11003988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leyson JF, Martin BF, Sporer A. Baclofen in the treatment of detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol. 1980;124:82–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7411729</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mertens P, Parise M, Garcia-Larrea L, Benneton C, Milet MF, Sindou M. Long-term clinical, electrophysiological and urodynamic effects of chronic intrathecal baclofen infusion for treatment of spinal spasticitiy. Acta Neurochir Suppl. 1995;64:17–25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8748577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor MC, Bates CP. A double-blind crossover trial of baclofen—a new treatment for the unstable bladder syndrome. Br J Urol. 1979;51:504–505.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">394795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyazato M, Sasatomi K, Hiragata S, Sugaya K, Chancellor MB, deGroat WC, Yoshimura N. GABA receptor activation in the lumbosacral spinal cord decreases detrusor overactivity in spinal cord injured rats. J Urol. 2008;179:178–1183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2744108</ArticleId>
            <ArticleId IdType="pubmed">18206170</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu D, Qu C, Meng H, Ren J, Min Z, Kong Y. Dysfunctional voiding confirmed by transdermal perineal electromyography and its effective treatment with baclofen in women with lower urinary tract symptoms: a randomized double-blind placebo controlled crossover trial. BJU Int. 2007;100:588–592.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17511770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sillen U, Persson B, Rubenson A. Central effects of baclofen on the L-dopa induced hyperactive urinary bladder of the rat. Naunyn Schmiedebergs Arch Pharmacol. 1985;330:175–178.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2414673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pehrson R, Lehmann A, Andersson KE. Effects of GABA-B receptor modulation on normal micturition and oxyhemoglobin induced detrusor overactivity in female rats. J Urol. 2002;168:2700–2705.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12442013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Igawa Y, Mattiasson A, Andersson KE. Effects of GABA-receptor stimulation and blockade on micturition in normal rats and rats with bladder outflow obstruction. J Urol. 1993;150:537–542.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8392118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andersson KE, Pehrson R. CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention. Drugs. 2003;63:2595–2611.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14636079</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tyacke RJ, Lingford-Hughes A, Reed LJ, Nutt DJ. GABA-B receptors in addiction and its treatment. Adv Pharmacol. 2010;58:373–396.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20655489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fadda P, Scherma M, Fresu A, Collu M, Fratta W. Baclofen antagonizes nicotine-, cocaine- and morphine-induced dopamine release in the nucleus accumbens of rat. Synapse. 2003;50:1–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12872287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paterson NE, Froestl W, Markou A. The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology. 2004;172:179–186.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14610636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramshini E, Alaei H, Reisi P, Alaei S, Shahidani S. The role of GABA B receptors in morphine self administration. In J Prev Med. 2013;4:158–164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3604847</ArticleId>
            <ArticleId IdType="pubmed">23542877</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Riahi E, Mirzaii-Dizgah I, Karimian SM, Roodsari HRS, Dehpour AR. Attenuation of morphine withdrawal signs by a GABA-B receptor agonist in the locus coeruleus of rats. Behavioral Brain Res. 2009;196:11–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18634832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Assadi SM, Radgoodarzi R, Ahmadi-Abhari S. Baclofen for maintenance treatment of opioid dependence: a randomized double-blind placebo-controlled clinical trial. BMC Psychiatry. 2003;3:16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC293465</ArticleId>
            <ArticleId IdType="pubmed">14624703</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saulino M. Simultaneous treatment of intractable pain and spasticity: observations of combined intrathecal baclofen-morphine therapy over a 10-year clinical experience. Eur J Phys Rehabil Med. 2012;48:39–45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21525824</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeFeudis FV. Gamma-Amino Butyric Acid-ergic analgesia: implications for gamma-aminobutyric acid-ergic therapy for drug addictions. Drug Alcohol Depend. 1984;14:101–111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6096107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Srivastava S, Hoon A, Ogborn J, Johnston M. Acute onset rhythmic hiccup-like respirations secondary to oral baclofen toxicity. Pediatr Neurol. 2014;51:252–254.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25079574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silversides JA, Scott KC. Diabetes insipidus following overdose of baclofen and quetiapine. Anaesth Intensive Care. 2009;37(2):319–320.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19400501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zarrindast MR, Khodjastehfar E, Oryan S, Torkaman-Boutorabi A. Baclofen-impairment of memory retention in rats: possible interaction with adrenoceptor mechanism(s) Eur J Pharmacol. 2001;411:283–286.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11164386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ross JC, Cook AM, Stewart GL, Fahy BG. Acute intrathecal baclofen withdrawal: a brief review of treatment options. Neurocrit Care. 2011;14:103–108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20717751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leung NY, Whyle IM, Isbister GK. Baclofen overdose: defining the spectrum of toxicitiy. Emerg Med Australias. 2006;18:77–82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16454779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hsieh JC, Penn RD. Intrathecal baclofen in the treatment of adult spasticity. Spinal Cord. 2010;48:483–486.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boster AL, Adair RL, Gooch JL, Nelson MES, Toomer A, Urquidez J, Saulino M. Best practices for intrathecal baclofen therapy: dosing and long-term management. Pain Manag. 2012;2:603–608.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27433993</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lioresal Intrathecal Product Insert. Reference ID: 2923078.</Citation>
        </Reference>
        <Reference>
          <Citation>Heetla HW, Staal MJ, Kliphuis C, Van Laar T. The incidence and management of tolerance in intrathecal baclofen therapy. Spinal Cord. 2009;47:751–756.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19333246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heetla HW, Staal MJ, Van Laar T. Tolerance to continuous intrathecal baclofen infusion can be reversed by pulsatile bolus infusion. Spinal Cord. 2009;48:483–486.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19918253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malcangio M, Bowery NG. Spinal cord SP release and hyperalgesia in monoarthritic rats: involvement of the GABA B receptor systems. Br J Pharmacol. 1994;113:1561–1566.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1510494</ArticleId>
            <ArticleId IdType="pubmed">7534191</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Enna SJ, Harstad EB, McCarson KE. Regulation of neurkinin-1 receptor expression by GABA(B) receptor agonists. Life Sci. 1998;62:1525–1530.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9585130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Melin C, Jacquot F, Dallel R, Artola A. Segmental disinhibition suppresses C-fiber inputs to the rat superficial medullary dorsal horn via the activation of GABA-B receptors. Eur J Neurosci. 2013;37:417–428.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23136905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ness TJ, Gebhart GF. Interactions between visceral and cutaneous nociception. I. Noxious cutaneous stimuli inhibit visceral nociceptive neurons and reflexes. J Neurophysiol. 1991;66:20–28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1919667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang K, Ma H. Blockade of GABA(B) receptors facilitates evoked neurotransmitter release at spinal dorsal horn synapse. Neuroscience. 2011;193:411–420.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21807068</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Franklin TR, Wang A, Sciortino N, Harper D, Li Y, Hakun J, Kildea S, Kampman K, Ehrman R, Detre JA, O’Brien CP, Childress AR. Modulation of resting brain cerebral blood flow by the GABA B agonist, baclofen: a longitudinal perfusion fMRI study. Drug Alcohol Depend. 2011;117:176–183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3348615</ArticleId>
            <ArticleId IdType="pubmed">21333466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ignatov ID, Andreev BV. Role of opioid and adrenergic mechanisms in the analgesic action of GABA-positive drugs. Biull Eksp Biol Med. 1988;105:556–558.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2838104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blednov YA, Stoffel M, Alva H, Harris RA. A pervasive mechanism for analgesia: activation of GIRK2 channels. Proc Natl Acad Sci USA. 2003;100:277–282.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC140950</ArticleId>
            <ArticleId IdType="pubmed">12493843</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
